TOP TIERMARKET NEWSWIRE

News & sentiment

VERAXA BIOTECH HLDG (VRXA) — News & AI sentiment

VERAXA BIOTECH HLDG (VRXA) news roundup. 1 story in the past week, 10 over 30 days. Average 30-day sentiment is 57.9/100. Recent insider activity (SEC Form 4, 90-day window): 2 purchases totalling $83K and 0 sales totalling $0 — net buying of $83K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 63/100

30d stories

10

avg sentiment 57.9/100

Insider net (90d)

$83K

2 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

VRXA news in the last 24 hours, 7 days, 30 days and 90 days

How much VRXA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	VRXA stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	63/100	VRXA headlines →
Last 30 days	10	57.9/100	VRXA headlines →
Last 90 days	26	59.6/100	VRXA headlines →

Latest stories on VRXA

VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress

Business Insider63 · neutralproduct/pr

3d ago

VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

Business Insider56 · neutralgeneral

Sep 18

VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

Business Insider63 · neutralproduct/pr

Sep 16

VERAXA Biotech Designates Raju Willener as CFO

Yahoo Finance55 · neutralgeneral

Sep 9

Veraxa Biotech stock rises after naming Raju Willener as CFO

Investing.com Markets56 · neutralgeneral

Sep 4

VERAXA Biotech names Raju Willener as CFO

Seeking Alpha55 · neutralgeneral

Sep 4

Veraxa Biotech appoints Raju Willener as CFO

The Fly56 · neutralgeneral

Sep 4

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Business Insider56 · neutralgeneral

Sep 4

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

GlobeNewswire56 · neutralgeneral

Sep 4

VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

Business Insider63 · neutralproduct/pr

Aug 28

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

Business Insider67 · bullishproduct/pr

Aug 25

Veraxa Biotech, Secarna announce initial results from AOC alliance

The Fly58 · neutralproduct/pr

Aug 24

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

GlobeNewswire65 · bullishproduct/pr

Aug 24

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

Business Insider65 · bullishproduct/pr

Aug 24

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies

Business Insider67 · bullishproduct/pr

Aug 6

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

Business Insider63 · neutralproduct/pr

Jul 29

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

StockTitan63 · neutralproduct/pr

Jul 27

VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth

StockTitan59 · neutralgeneral

Jul 24

VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth

Business Insider63 · neutralgeneral

Jul 24

VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio

Business Insider56 · neutralproduct/pr

Jul 23

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

StockTitan63 · neutralproduct/pr

Jul 20

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline | VRXA Stock News

StockTitan63 · neutralproduct/pr

Jul 13

VERAXA Biotech appoints interim CFO

Seeking Alpha50 · neutralgeneral

Jul 10

VRXA - Veraxa Biotech Ag Stock Price

Barchart50 · neutralgeneral

Jul 8

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines | VRXA Stock News

StockTitan56 · neutralproduct/pr

Jul 6

Open VRXA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →